Status
ACTIVE
Global HQ
Paris, France
Countries of investment
- France
Investment stages
- Seed
- Series A
Industries
- Health Tech
- Biotechnology
About
iBionext is a pioneering start-up studio and investment fund dedicated to creating, developing, and funding innovative HealthTech start-ups at the intersection of scientific disciplines. We specialize in identifying and nurturing disruptive projects worldwide, leveraging our expertise to transform groundbreaking ideas into viable solutions that address pressing healthcare challenges. Our mission is to drive advancements in health technology by fostering collaboration among entrepreneurs, researchers, and industry leaders, ensuring that transformative innovations can reach the market effectively and sustainably. At iBionext, we are committed to reshaping the future of healthcare and improving patient outcomes through strategic investments and hands-on support.
iBionext is a pioneering start-up studio and investment fund dedicated to creating, developing, and funding innovative HealthTech start-ups at the intersection of scientific disciplines. We specialize in identifying and nurturing disruptive projects worldwide, leveraging our expertise to transform groundbreaking ideas into viable solutions that address pressing healthcare challenges. Our mission is to drive advancements in health technology by fostering collaboration among entrepreneurs, researchers, and industry leaders, ensuring that transformative innovations can reach the market effectively and sustainably. At iBionext, we are committed to reshaping the future of healthcare and improving patient outcomes through strategic investments and hands-on support.
Investment Thesis
iBionext focuses on the creation, development, and financing of innovative startups, providing new and disruptive solutions to medical problems and developing deep tech, bioinspired, intelligent, and energyefficient industrial solutions.
Manager's Experience
Bringing a wealth of experience, the fund manager has successfully executed over 30 deals across sectors such as technology, healthcare, and renewable energy, with a strong emphasis on operator-first strategies. Active primarily in North America and Europe, the manager showcases a data-driven approach to investments, focusing on early to growth-stage opportunities. Notable exits have included several high-profile acquisitions, underscoring a commitment to maximizing returns for stakeholders. Their thematic investment style emphasizes innovation and scalability, making them a formidable player in the venture capital landscape.
Team
Christophe Bancel
Alexia Perouse
Stephane Losik
Muriel Badawi
Bernard Gilly
Sylvie Murgo